These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10815773)

  • 1. Conformational analysis of a farnesyltransferase peptide inhibitor, CVIM.
    Carlacci L
    J Comput Aided Mol Des; 2000 May; 14(4):369-82. PubMed ID: 10815773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational analysis of [Met5]-enkephalin: solvation and ionization considerations.
    Carlacci L
    J Comput Aided Mol Des; 1998 Mar; 12(2):195-213. PubMed ID: 9690177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation of a heptapeptide substrate bound to protein farnesyltransferase.
    Stradley SJ; Rizo J; Gierasch LM
    Biochemistry; 1993 Nov; 32(47):12586-90. PubMed ID: 8251476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational analysis of two similar neuropeptides yields distinct conformational ensembles.
    Carlacci L; Edison AS
    Proteins; 2000 Aug; 40(3):367-77. PubMed ID: 10861928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and structural requirements of potent peptidomimetic inhibitors of p21ras farnesyltransferase.
    Qian Y; Blaskovich MA; Saleem M; Seong CM; Wathen SP; Hamilton AD; Sebti SM
    J Biol Chem; 1994 Apr; 269(17):12410-3. PubMed ID: 8175645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the bioactive conformation of the farnesyltransferase protein binding recognition motif by computational methods.
    Corcho FJ; Filizola M; Perez JJ
    J Biomol Struct Dyn; 1999 Apr; 16(5):1043-52. PubMed ID: 10333174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of farnesyltransferase and Ras processing peptidase.
    Hall CC; Watkins JD; Ferguson SB; Foley LH; Georgopapadakou NH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):728-32. PubMed ID: 8554591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of human tumor p21ras farnesyltransferase by A1A2-lacking p21ras CA1A2X peptidomimetics.
    Nigam M; Seong CM; Qian Y; Hamilton AD; Sebti SM
    J Biol Chem; 1993 Oct; 268(28):20695-8. PubMed ID: 8407887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudopeptide inhibitors of Ras farnesyl-protein transferase.
    Graham SL; deSolms SJ; Giuliani EA; Kohl NE; Mosser SD; Oliff AI; Pompliano DL; Rands E; Breslin MJ; Deana AA
    J Med Chem; 1994 Mar; 37(6):725-32. PubMed ID: 8145221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of the 20-residue membrane-bound portion of melittin by conformational space annealing.
    Lee J; Scheraga HA; Rackovsky S
    Biopolymers; 1998 Aug; 46(2):103-16. PubMed ID: 9664844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of a 12-residue loop in bovine pancreatic trypsin inhibitor: effects of buried water.
    Carlacci L
    Biopolymers; 2001 Apr; 58(4):359-73. PubMed ID: 11180050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrapeptide inhibitors of protein farnesyltransferase: amino-terminal substitution in phenylalanine-containing tetrapeptides restores farnesylation.
    Brown MS; Goldstein JL; Paris KJ; Burnier JP; Marsters JC
    Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8313-6. PubMed ID: 1518863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of tripeptidyl farnesyltransferase inhibitors.
    Lee HY; Sohn JH; Kwon BM
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1599-602. PubMed ID: 12039571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermodynamics and mechanism of alpha helix initiation in alanine and valine peptides.
    Tobias DJ; Brooks CL
    Biochemistry; 1991 Jun; 30(24):6059-70. PubMed ID: 2043644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Farnesyltransferase inhibitors: a new class of cancer chemotherapeutics.
    Koblan KS; Kohl NE; Omer CA; Anthony NJ; Conner MW; deSolms SJ; Williams TM; Graham SL; Hartman GD; Oliff A; Gibbs JB
    Biochem Soc Trans; 1996 Aug; 24(3):688-92. PubMed ID: 8878827
    [No Abstract]   [Full Text] [Related]  

  • 16. Probing the hydrophobic pocket of farnesyltransferase: aromatic substitution of CAAX peptidomimetics leads to highly potent inhibitors.
    Qian Y; Marugan JJ; Fossum RD; Vogt A; Sebti SM; Hamilton AD
    Bioorg Med Chem; 1999 Dec; 7(12):3011-24. PubMed ID: 10658608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational analysis of endothelin-1: effects of solvation free energy.
    Hempel JC; Fine RM; Hassan M; Ghoul W; Guaragna A; Koerber SC; Li Z; Hagler AT
    Biopolymers; 1995 Sep; 36(3):283-301. PubMed ID: 7669916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamics of a reverse turn motif. Solvent effects and side-chain packing.
    Demchuk E; Bashford D; Gippert GP; Case DA
    J Mol Biol; 1997 Jul; 270(2):305-17. PubMed ID: 9236131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Farnesylation of p21 Ras proteins in Xenopus oocytes.
    Zhao J; Kung HF; Manne V
    Cell Mol Biol Res; 1994; 40(4):313-21. PubMed ID: 7866432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of mono- and bisubstrate inhibitors of protein farnesyltransferase and inducers of apoptosis from a pepticinnamin E library.
    Thutewohl M; Kissau L; Popkirova B; Karaguni IM; Nowak T; Bate M; Kuhlmann J; Müller O; Waldmann H
    Bioorg Med Chem; 2003 Jun; 11(12):2617-26. PubMed ID: 12757727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.